623
Participants
Start Date
June 30, 2017
Primary Completion Date
August 31, 2020
Study Completion Date
August 31, 2020
Blood sample
Six ml of blood will be collected from patients in an EDTA tube. 2 ml saliva samples in Oragene DNA collection kits
Patient questionnaires
Questionnaires will be completed at the baseline and annual follow-up visits to collect data that will define the demographics of the pediatric ARP and CP cohort, describe risk factors, presence of family history of acute and chronic pancreatitis, diabetes and pancreatic cancer and assess disease burden and sequelae.
Saliva sample
2 ml saliva samples in Oragene DNA collection kits collected if no blood sample being collected.
Urine sample
50 ml of urine in collection container.
Sydney Children's Hospital Randwick, Randwick
Children's Hospital of Pittsburgh, Pittsburgh
Children's Hospital of Philadelphia, Philipsburg
Nationwide Children's Hospital, Columbus
Cincinnati Children's Hospital Medical Center, Cincinnati
Riley Hospital for Children Indiana University, Indianapolis
University of Iowa Stead Family Children's Hospital, Iowa City
Medical College of Wisconsin, Milwaukee
University of Minnesota Medical Center, Minneapolis
Washington University, St Louis
Children's Health University of Texas Southwestern Medical Center, Dallas
Texas Children's Hospital, Houston
Primary Children's Hospital, Salt Lake City
Children's Hospital Los Angeles, Los Angeles
Cedars-Sinai Medical Center, Beverly Hills
Hadassah University Hospital Mt. Scopus, Jerusalem
University of California San Francisco, San Francisco
Stanford University, Stanford
Seattle Children's Hospital, Seattle
Massachusetts General Hospital, Boston
The Hospital for Sick Children, Toronto
Montreal Children's Hospital, Montreal
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
National Cancer Institute (NCI)
NIH
Aliye Uc
OTHER